Suchergebnisse - "GPI-Linked Proteins"

PubPharm (724)

81

Evaluation of Cyclophosphamide/GVAX Pancreas Followed by Listeria-Mesothelin (CRS-207) with or without Nivolumab in Patients with Pancreatic Cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Tsujikawa, T. | Crocenzi, T. | Durham, J. | +18

82

Enhanced efficacy of mesothelin-targeted immunotoxin LMB-100 and anti-PD-1 antibody in patients with mesothelioma and mouse tumor models

enthalten in: Science translational medicine | 2020

von Jiang, Q. | Ghafoor, A. | Mian, I. | +10

83

Mesothelin-Targeted Recombinant Immunotoxins for Solid Tumors

enthalten in: Biomolecules | 2020

von Hagerty, B. | Pegna, G. | Xu, J. | +2

84

Protease-activation using anti-idiotypic masks enables tumor specificity of a folate receptor 1-T cell bispecific antibody

enthalten in: Nature communications | 2020

von Geiger, M. | Stubenrauch, K. | Sam, J. | +18

85

Construction and Functional Characterization of a Fully Human Anti-mesothelin Chimeric Antigen Receptor (CAR) Expressing T Cell

enthalten in: Iranian journal of allergy, asthma, and immunology | 2020

von Jafarzadeh, L. | Masoumi, E. | Alishah, K. | +8

86

Killing cervical cancer cells by specific chimeric antigen receptor-modified T cells

enthalten in: Journal of reproductive immunology | 2020

von He, Y. | Li, X. | Yin, C. | +1

87

From Malignant Progression to Therapeutic Targeting : Current Insights of Mesothelin in Pancreatic Ductal Adenocarcinoma

enthalten in: International journal of molecular sciences | 2020

von Montemagno, C. | Cassim, S. | Pouyssegur, J. | +2

88

First-in-Human, Multicenter, Phase I Dose-Escalation and Expansion Study of Anti-Mesothelin Antibody-Drug Conjugate Anetumab Ravtansine in Advanced or Metastatic Solid Tumors

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Hassan, R. | Blumenschein, G. | Moore, K. | +13

89

Construction and Preclinical Evaluation of a 124/131I-Labeled Radiotracer for the Detection of Mesothelin-Overexpressing Cancer

enthalten in: Molecular pharmaceutics | 2020

von Wang, X. | Wang, F. | Han, J. | +3

90

Putative Biomarkers for Malignant Pleural Mesothelioma Suggested by Proteomic Analysis of Cell Secretome

enthalten in: Cancer genomics & proteomics | 2020

von Lacerenza, S. | Ciregia, F. | Giusti, L. | +10